Persistent Effect of Arimoclomol in Patients with Niemann-Pick Disease Type C: 24-Month Results from an Open-Label Extension of a Pivotal Phase 2/3 Study
Neuropediatrics | November 17, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1055/s-0041-1739640